Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct fetal versus maternal betamethasone for late preterm delivery in women with pregestational diabetes
ACTRN12616001577404Phase 2Not yet recruiting
- Sponsor
- Women's and Newborn Health Service
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of betamethasone sodium and betamethasone in preterm birth (2 arms), sponsored by Women's and Newborn Health Service. Primary endpoints: Primary composite maternal metabolic endpoint, Maternal hyperglycaemia and 1 more. Planned start Dec 2016; status: not yet recruiting.
02
Drugs
betamethasone sodiumbetamethasone
03
Conditions
preterm birth
Beyond the preview
Go deeper on ACTRN12616001577404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001577404.